Effects of tumor-expressed coagulation factors on cancer progression and venous thrombosis: is there a key factor?

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Thrombosis Research

• Publication date

  2014-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0049-3848(14)50013-8PMID 24862150
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Acquired and inherited risk factors for the developing of venous thromboembolism in cancer patients receiving adjuvant chemotherapy: A prospective trial.

  2016cited by this paper
• Hemostasis, Thrombosis, and Vascular Biology: Inhibition of tissue factor signaling suppresses tumor growth

  2014cited by this paper
• Alternatively spliced tissue factor contributes to tumor spread and activation of coagulation in pancreatic ductal adenocarcinoma

  2014cited by this paper
• Activation of blood coagulation in cancer: implications for tumour progression

  2013cited by this paper
• Regional lymph node metastases are a strong risk factor for venous thromboembolism: results from the Vienna Cancer and Thrombosis Study

  2013cited by this paper
• Coagulation‐related gene expression profile in glioblastoma is defined by molecular disease subtype

  2013cited by this paper
• Biomarkers for prediction of venous thromboembolism in cancer.

  2013cited by this paper
• Alternatively spliced tissue factor promotes breast cancer growth in a β1 integrin-dependent manner

  2013cited by this paper
• Tissue factor‐integrin interactions in cancer and thrombosis: every Jack has his Jill

  2013cited by this paper
• Tumour and microparticle tissue factor expression and cancer thrombosis.

  2013cited by this paper
• Protein Z/protein Z-dependent protease inhibitor system in loco in human gastric cancer

  2013cited by this paper
• Physiological levels of blood coagulation factors IX and X control coagulation kinetics in an in vitro model of circulating tissue factor

  2013cited by this paper
• Tissue factor isoforms in cancer and coagulation: may the best isoform win.

  2012cited by this paper
• Clinical significance of circulating microparticles for venous thrombo - embolism in cancer patients

  2012cited by this paper
• Genetic pathways linking hemostasis and cancer.

  2012cited by this paper
• The tick‐derived inhibitor Ixolaris prevents tissue factor signaling on tumor cells

  2012cited by this paper
• Novel high-sensitive D-dimer determination predicts chemotherapy-associated venous thromboembolism in intermediate risk lung cancer patients.

  2012cited by this paper
• High D-dimer levels are associated with poor prognosis in cancer patients

  2012cited by this paper
• Microparticle‐associated tissue factor activity, venous thromboembolism and mortality in pancreatic, gastric, colorectal and brain cancer patients

  2012cited by this paper
• The relationship between tissue factor and cancer progression: insights from bench and bedside.

  2012cited by this paper
• Protein Z/protein Z-dependent protease inhibitor system in human non-small-cell lung cancer tissue.

  2012cited by this paper
• Co-localization of Protein Z, Protein Z-Dependent protease inhibitor and coagulation factor X in human colon cancer tissue: implications for coagulation regulation on tumor cells.

  2012influential reference
• Coagulation activation and microparticle-associated coagulant activity in cancer patients

  2012cited by this paper
• Hemostatic factors, innate immunity and malignancy.

  2012cited by this paper
• Protein Z is present in human breast cancer tissue

  2011cited by this paper
• Splice variants of tissue factor promote monocyte‐endothelial interactions by triggering the expression of cell adhesion molecules via integrin‐mediated signaling

  2011cited by this paper
• Prediction of venous thromboembolism in patients with cancer by measuring thrombin generation: results from the Vienna Cancer and Thrombosis Study.

  2011cited by this paper
• p38 MAPK controls prothrombin expression by regulated RNA 3' end processing.

  2011influential reference
• Circulating procoagulant microparticles in cancer patients

  2011cited by this paper
• Tissue factor and cell signalling in cancer progression and thrombosis

  2011cited by this paper
• P2X7 receptor signaling contributes to tissue factor-dependent thrombosis in mice.

  2011influential reference
• Acquired and inherited risk factors for developing venous thromboembolism in cancer patients receiving adjuvant chemotherapy: a prospective trial.

  2010cited by this paper
• Oral thrombostatin FM19 inhibits prostate cancer

  2010cited by this paper
• Cooperation of tissue factor cytoplasmic domain and PAR2 signaling in breast cancer development.

  2010cited by this paper
• Cancer-associated thrombosis

  2010cited by this paper
• Extrahepatic synthesis of coagulation factor VII by colorectal cancer cells promotes tumor invasion and metastasis.

  2010influential reference
• Microparticle-associated tissue factor activity and venous thrombosis in multiple myeloma

  2010cited by this paper
• Oncogenic epidermal growth factor receptor up-regulates multiple elements of the tissue factor signaling pathway in human glioma cells.

  2010cited by this paper
• D-dimer before chemotherapy might predict venous thromboembolism

  2009cited by this paper
• Preoperative Plasma D-Dimer Is a Predictor of Postoperative Deep Venous Thrombosis in Colorectal Cancer Patients: A Clinical, Prospective Cohort Study with One-Year Follow-Up

  2009cited by this paper
• Self-production of tissue factor-coagulation factor VII complex by ovarian cancer cells

  2009influential reference
• Human alternatively spliced tissue factor is not secreted and does not trigger coagulation

  2009cited by this paper
• Venous Thromboembolism: Mechanisms, Treatment, and Public Awareness Biomarkers and Venous Thromboembolism

  2009cited by this paper
• Cancer, clots and consensus: new understanding of an old problem.

  2009influential reference
• Microparticle‐associated tissue factor activity in cancer patients with and without thrombosis

  2009influential reference
• Tumor-derived microvesicles modulate the establishment of metastatic melanoma in a phosphatidylserine-dependent manner.

  2009cited by this paper
• Ixolaris, a tissue factor inhibitor, blocks primary tumor growth and angiogenesis in a glioblastoma model

  2009cited by this paper
• Cancer cell–derived microparticles bearing P-selectin glycoprotein ligand 1 accelerate thrombus formation in vivo

  2009cited by this paper
• Evidence for increased expression of tissue factor and protease-activated receptor-1 in human esophageal cancer.

  2009cited by this paper
• D-dimer and prothrombin fragment 1 + 2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study.

  2009cited by this paper
• Alternatively spliced tissue factor induces angiogenesis through integrin ligation

  2009cited by this paper
• Tumor-Derived Tissue FactorBearing Microparticles Are Associated With Venous Thromboembolic Events in Malignancy

  2009influential reference
• Hepatocyte Nuclear Factor-4–Independent Synthesis of Coagulation Factor VII in Breast Cancer Cells and Its Inhibition by Targeting Selective Histone Acetyltransferases

  2009influential reference
• Microarray studies of factor VIIa-activated cancer cells.

  2008cited by this paper
• Protease-activated receptor (PAR) 2, but not PAR1, signaling promotes the development of mammary adenocarcinoma in polyoma middle T mice.

  2008cited by this paper
• Anti cancer effects of curcumin: cycle of life and death

  2008cited by this paper
• Tissue factor expression pattern in human non-small cell lung cancer tissues indicate increased blood thrombogenicity and tumor metastasis.

  2008cited by this paper
• Harmful molecular mechanisms in sepsis

  2008cited by this paper
• Stromal gene expression predicts clinical outcome in breast cancer

  2008cited by this paper
• Microparticle‐associated tissue factor activity: a link between cancer and thrombosis?

  2007influential reference
• The tissue factor–factor VIIa complex: procoagulant activity, regulation, and multitasking

  2007cited by this paper
• Tumor cell-associated tissue factor and circulating hemostatic factors cooperate to increase metastatic potential through natural killer cell-dependent and-independent mechanisms.

  2007influential reference
• Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy

  2007cited by this paper
• Alternatively spliced human tissue factor promotes tumor growth and angiogenesis in a pancreatic cancer tumor model.

  2007influential reference
• Cancer-associated thrombosis.

  2007cited by this paper
• Microparticles and Cancer

  2007cited by this paper
• High incidence of silent venous thromboembolism before treatment in ovarian cancer

  2007cited by this paper
• Tissue Factor Expression, Angiogenesis, and Thrombosis in Pancreatic Cancer

  2007influential reference
• Activation of cancer cell migration and invasion by ectopic synthesis of coagulation factor VII.

  2006cited by this paper
• Hypoxia enhances lysophosphatidic acid responsiveness in ovarian cancer cells and lysophosphatidic acid induces ovarian tumor metastasis in vivo.

  2006cited by this paper
• Are hemostasis and thrombosis two sides of the same coin?

  2006cited by this paper
• Alternatively spliced human tissue factor (asHTF) is not pro-coagulant

  2006cited by this paper
• Two functional modes of a nuclear receptor-recruited arginine methyltransferase in transcriptional activation.

  2006cited by this paper
• Thrombin induces tumor growth, metastasis, and angiogenesis: Evidence for a thrombin-regulated dormant tumor phenotype.

  2006influential reference
• Sp1 Deacetylation Induced by Phorbol Ester Recruits p300 To Activate 12(S)-Lipoxygenase Gene Transcription

  2006cited by this paper
• Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer

  2005cited by this paper
• Autocrine Role of Interleukin-8 in Induction of Endothelial Cell Proliferation, Survival, Migration and MMP-2 Production and Angiogenesis

  2005cited by this paper
• Cyclic strain-mediated regulation of vascular endothelial cell migration and tube formation.

  2005cited by this paper
• Ovarian cancer and venous thromboembolic risk.

  2005cited by this paper
• Procoagulant Soluble Tissue Factor Is Released From Endothelial Cells in Response to Inflammatory Cytokines

  2005influential reference
• Atherosclerosis in Mice Is Not Affected by a Reduction in Tissue Factor Expression

  2005cited by this paper
• Cross-talk of integrin alpha3beta1 and tissue factor in cell migration.

  2004cited by this paper
• Tissue factor-factor VIIa-specific up-regulation of IL-8 expression in MDA-MB-231 cells is mediated by PAR-2 and results in increased cell migration.

  2004influential reference
• Cross-talk of integrin α3β1 and tissue factor in cell migration

  2004cited by this paper
• Regulation of angiogenesis by tissue factor cytoplasmic domain signaling

  2004cited by this paper
• Formation of tissue factor–factor VIIa–factor Xa complex promotes cellular signaling and migration of human breast cancer cells

  2004cited by this paper
• Tissue factor: (patho)physiology and cellular biology

  2004cited by this paper
• Shedding of tissue factor (TF)‐containing microparticles rather than alternatively spliced TF is the main source of TF activity released from human cancer cells

  2004cited by this paper
• Coagulation factors VIIa and Xa inhibit apoptosis and anoikis

  2004cited by this paper
• Regeneration: every clot has a thrombin lining.

  2003cited by this paper
• Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic protein

  2003influential reference
• Tissue factor/factor VIIa inhibitors block angiogenesis and tumor growth through a nonhemostatic mechanism.

  2003cited by this paper
• Impact of pretreatment thrombocytosis on survival in primary breast cancer

  2003cited by this paper
• Aberrant expression and activation of the thrombin receptor protease-activated receptor-1 induces cell proliferation and motility in human colon cancer cells.

  2003cited by this paper
• Differential role of tissue factor pathway inhibitors 1 and 2 in melanoma vasculogenic mimicry.

  2003cited by this paper
• Antiapoptotic effect of coagulation factor VIIa.

  2003cited by this paper
• Extrahepatic Synthesis of Factor VII in Human Atherosclerotic Vessels

  2003cited by this paper
• The fibronectin-binding integrins α5β1 and αvβ3 differentially modulate RhoA–GTP loading, organization of cell matrix adhesions, and fibronectin fibrillogenesis

  2002cited by this paper
• Ixolaris, a novel recombinant tissue factor pathway inhibitor (TFPI) from the salivary gland of the tick, Ixodes scapularis: identification of factor X and factor Xa as scaffolds for the inhibition of factor VIIa/tissue factor complex.

  2002cited by this paper
• Mechanistic coupling of protease signaling and initiation of coagulation by tissue factor

  2001cited by this paper

• A Venous Thromboembolism-Associated Model for Predicting Tumor Microenvironment Features in Breast Cancer.

  2026cites this paper
• Predicting Preoperative Deep Vein Thrombosis in Elderly Hip Fracture Patients Using an Interpretable Machine Learning Model

  2025cites this paper
• Endothelial cell dysfunction in cancer: a not-so-innocent bystander

  2024influential citation
• Combining KRAS gene status with preoperative D‑dimer levels as a predictive marker of venous thromboembolism risk in patients with resectable colorectal cancer: A prospective cohort study

  2024cites this paper
• Haemostatic gene variations in cervical cancer-associated venous thrombosis: considerations for clinical strategies

  2024cites this paper
• Venous thromboembolism and ovarian cancer risk: a Mendelian randomized study

  2024cites this paper
• The breast cancer coagulome in the tumor microenvironment and its role in prognosis and treatment response to chemotherapy.

  2024cites this paper
• Risk factors and prediction model of nomogram for preoperative calf muscle vein thrombosis in geriatric hip fracture patients

  2023cites this paper
• Tissue factor positive microparticles as a biomarker for increased risk of breast cancer-associated thrombosis: a mini review

  2023cites this paper
• Determination of Survival of Gastric Cancer Patients With Distant Lymph Node Metastasis Using Prealbumin Level and Prothrombin Time: Contour Plots Based on Random Survival Forest Algorithm on High-Dimensionality Clinical and Laboratory Datasets

  2022cites this paper
• Tissue factor as a new target for tumor therapy—killing two birds with one stone: a narrative review

  2022cites this paper
• Blood coagulation and cancer genes.

  2022cites this paper
• Venous Thromboembolism in Cancer and Cancer Immunotherapy.

  2022cites this paper
• Tumour-Associated Tissue Factor (TF)-mRNA Is A Precursor for Rapid TF-Microvesicle Release and A Potential Predictive Marker for the Risk of Pulmonary Embolism (PE) in Gastrointestinal Cancer Patients

  2022cites this paper
• Venous thromboembolism and prostate cancer: what about genetic markers?

  2021cites this paper
• Progress in laboratory research on venous thromboembolism complicated with malignant tumor diseases

  2020cites this paper
• Screening and identification of key genes and pathways in metastatic uveal melanoma based on gene expression using bioinformatic analysis

  2020cites this paper
• Dramatic decreases of all haemorrhagic coagulation factors by acquired inhibitors after extended left lobectomy

  2019cites this paper
• Atrial fibrillation and cancer - An unexplored field in cardiovascular oncology.

  2019cites this paper
• Venous thromboembolism GWAS reported genetic makeup and the hallmarks of cancer: Linkage to ovarian tumour behaviour.

  2019cites this paper
• The intertwined fates of inflammation and coagulation in glioma

  2018cites this paper
• Protease‐activated receptor 2 promotes actomyosin dependent transforming microvesicles generation from human breast cancer

  2018cites this paper
• Cancer‐associated thrombosis: The search for the holy grail continues

  2018cites this paper
• The coagulome and the oncomir: impact of cancer-associated haemostatic dysregulation on the risk of metastasis

  2018cites this paper
• Genes associated with venous thromboembolism in colorectal cancer patients

  2018cites this paper
• Epithelial–mesenchymal plasticity and circulating tumor cells: Travel companions to metastases

  2018cites this paper
• Anti-IIa activity and antitumor properties of a hybrid heparin/heparan sulfate-like compound from Litopenaeus vannamei shrimp.

  2018cites this paper
• Recent Progress in Research on the Pathogenesis of Pulmonary Thromboembolism: An Old Story with New Perspectives

  2017cites this paper
• Role of Tissue Factor-FVIIa Blood Coagulation Initiation Complex in Cancer

  2017cites this paper
• Efficacy and safety of apatinib combined with transarterial chemoembolization for hepatocellular carcinoma with portal venous tumor thrombus: a retrospective study

  2017cites this paper
• Understanding and treating solid tumor–related disseminated intravascular coagulation in the “era” of targeted cancer therapies

  2017cites this paper
• A minor role of asparaginase in predisposing to cerebral venous thromboses in adult acute lymphoblastic leukemia patients

  2017cites this paper
• Reciprocal links between venous thromboembolism, coagulation factors and ovarian cancer progression.

  2017cites this paper
• Proliferation.

  2017cites this paper
• Interplay between alternatively spliced Tissue Factor and full length Tissue Factor in modulating coagulant activity of endothelial cells.

  2017cites this paper
• Thrombin—unique coagulation system protein with multifaceted impacts on cancer and metastasis

  2016cites this paper
• Mass spectrometry of extracellular vesicles.

  2016cites this paper
• Routine Hemostasis and Hemogram Parameters: Valuable Assessments for Coagulation Disorder and Chemotherapy in Cancer Patients

  2016cites this paper
• Tissue Factor Induced by Epithelial-Mesenchymal Transition Triggers a Procoagulant State That Drives Metastasis of Circulating Tumor Cells.

  2016cites this paper
• VEGF gene promoter polymorphisms and risk of VTE in chemotherapy-treated cancer patients

  2016cites this paper
• Thrombosis in colorectal cancer

  2016cites this paper
• Tissue Factor: Old and New Links with Cancer Biology

  2015cites this paper
• Protease-activated receptors (PARs)—biology and role in cancer invasion and metastasis

  2015influential citation
• Elevated preoperative plasma D-dimer level is a useful predictor of chemoresistance and poor disease outcome for serous ovarian cancer patients

  2015cites this paper
• Measurement of procoagulant activity of microparticles in plasma: feasibility of new functional assays.

  2014cites this paper
• Extracellular Vesicles in Hematological Disorders

  2014cites this paper